NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/07/2025
Back to search
Official data from USPTO
INNOVATION COMPOUNDING CUSTOM MEDICATIONS. OPTIMAL OUTCOMES.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/08/2025
Trademark type
Combined
Nice classes
40
Filing date
10/12/2018
Registration date
06/11/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/07/2025
Last transaction
08/08/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
01/31/2007
First use in commerce
01/31/2007
Drawing code
3
Owner type
16
Owner location
KENNESAW, GA
Examiner
PARK, JENNY
Current location
Historical data usage
Mark description
The mark consists of the word "Innovation" above and left-justified with the word "Compounding", below which appears "Custom Mediations. Optimal Outcomes." and too the left of all of this is a shield that is bifurcated vertically, the left side containing an Erlynmeyer flask, and the right containing a pill bottle with two pills above it, and over the shield is the top third of a caduceus showing a staff, wings, and the heads and partial bodies of two snakes facing each other.
Holders and representatives
Holders
REVELATION PHARMA MANAGEMENT , LLC
Innovation Compounding, Inc.
Representatives
Deborah L. Lively Pierson Ferdinand LLP
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of pharmaceuticals by pharmaceutical compounders
Publications
History of USPTO decisions and trademark events.
28 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/07/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/11/2025
E815
TEAS SECTION 8 & 15 RECEIVED
04/04/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/11/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/14/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/25/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/23/2022
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
04/19/2022
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
04/19/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/13/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
09/26/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2019
PUBO
PUBLISHED FOR OPPOSITION
03/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2019
ALIE
ASSIGNED TO LIE
02/15/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/30/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/30/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/30/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/30/2019
DOCK
ASSIGNED TO EXAMINER
01/23/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/24/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/23/2018
NWAP
NEW APPLICATION ENTERED
10/16/2018
Continuous trademark protection
Get notified about every new filing that threatens INNOVATION COMPOUNDING CUSTOM MEDICATIONS. OPTIMAL OUTCOMES. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.